Dong-A Socio Holdings Co., Ltd. (KRX:000640)

South Korea flag South Korea · Delayed Price · Currency is KRW
121,000
-900 (-0.74%)
At close: Dec 5, 2025
21.47%
Market Cap 778.72B
Revenue (ttm) 1.40T
Net Income (ttm) 107.66B
Shares Out 6.44M
EPS (ttm) 16,724.68
PE Ratio 7.23
Forward PE 6.83
Dividend 1,650.49 (1.36%)
Ex-Dividend Date Jul 30, 2025
Volume 7,311
Average Volume 18,358
Open 121,200
Previous Close 121,900
Day's Range 119,300 - 122,000
52-Week Range 90,583 - 125,300
Beta -0.10
RSI 71.62
Earnings Date Feb 9, 2026

About Dong-A Socio Holdings

Dong-A Socio Holdings Co., Ltd., together with its subsidiaries, engages in the pharmaceutical business in South Korea. It operates through Holding Company; Over-the-Counter Drugs and Quai-Drugs; Biosimilars and Consignment Medicines; Logistics; Packaging Solutions; and Others segments. The company develops DA-8010 in Phase 3 clinical trial to treat overactive bladder; DMB-3115, a biosimilar of Stelara in Phase 3 clinical trial; DA-1241 in Phase 2 clinical trial for the treatment of non-alcoholic steatohepatitis; DA-1726 in Phase 1 clinical tri... [Read more]

Sector Healthcare
Founded 1932
Employees 5,653
Stock Exchange Korea Stock Exchange
Ticker Symbol 000640
Full Company Profile

Financial Performance

In 2024, Dong-A Socio Holdings's revenue was 1.33 trillion, an increase of 17.78% compared to the previous year's 1.13 trillion. Earnings were 58.02 billion, an increase of 0.06%.

Financial Statements

News

There is no news available yet.